drugset / Trial / NCT03204578
Physiological Study of the Human CYP3A Activity (PiSA)
RandomizedCrossoverOpen-labelTreatment
Summary
Investigator-initiated physiological study to characterize the function of a major drug metabolizing enzyme using a microdosed phenotyping probe to avoid unwanted, concentration-dependent effects.
Timeline
- Start
- 2017-08-18
- Primary completion
- 2017-09-25
- Completion
- 2017-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | 30 ug | Oral |
Indications
No indication recorded.